Revision of Definition of Compendia as Authoritative Source for Use in the Determination of a Medically-Accepted Indication of Drugs/Biologicals Used Off-label in Anti-Cancer Chemotherapeutic Regimens
Effective January 1, 2010, pursuant to section 182(b) of MIPPA, CMS is making corresponding revisions in Pub. 100-02, Medicare Benefit Policy Manual, chapter 15, section 50.4.5, for use in the
etermination of a medically-accepted indication of drugs and biologicals used off-label in an anti-cancer chemotherapeutic regimen.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 29, 2010
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.